Purpose: Pancreatic adenocarcinoma (PAAD) presents an extremely high morbidity and mortality rate. Broccoli has excellent anti-cancer properties. However, the dosage and serious side effects still limit the application of broccoli and its derivatives for cancer therapy. Recently, extracellular vesicles (EVs) derived from plants are emerging as novel therapeutic agents. Thus, we conducted this study to determine the effectiveness of EVs isolated from Se-riched broccoli (Se-BDEVs) and conventional broccoli (cBDEVs) for the treatment of PAAD. Methods: In this study, we first isolated Se-BDEVs and cBDEVs by a differential centrifugation method, and characterized them by using nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Then, miRNA-seq was combined with target genes prediction, and functional enrichment analysis to reveal the potential function of Se-BDEVs and cBDEVs. Finally, the functional verification was conducted in PANC-1 cells. Results: Se-BDEVs and cBDEVs exhibited similar characteristics in size and morphology. Subsequent miRNA-seq revealed the expression of miRNAs in Se-BDEVs and cBDEVs. Using a combination of miRNA target prediction and KEGG functional analysis, we found miRNAs in Se-BDEVs and cBDEVs may play an important role in treating pancreatic cancer. Indeed, our in vitro study showed that Se-BDEVs had greater anti-PAAD potency than cBDEVs due to increased bna-miR167a_R-2 (miR167a) expression. Transfection with miR167a mimics significantly induced apoptosis of PANC-1 cells. Mechanistically, further bioinformatics analysis showed that IRS1, which is involved in the PI3K-AKT pathway, is the key target gene of miR167a. Conclusion: This study highlights the role of miR167a transported by Se-BDEVs which could be a new tool for counteracting tumorigenesis. Graphical Abstract:
24 November 2022 in The Journal of Nutritional Biochemistry
Background: Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma (TL-LGNPPA) is a rare nasopharyngeal malignant tumor that is easy to misdiagnose. Immunohistochemistry plays an indispensable role in distinguishing TL-LGNPPA from other malignancies. However, there is no article to summarize the immunohistochemical characteristics of TL-LGNPPA. Herein, we report a case of TL-LGNPPA and present the immunohistochemical results reported in the Chinese literature. Methods: An electronic search of the CNKI (China National Knowledge Infrastructure) database was performed. From our literature survey, 53 cases of TL-LGNPPA (including the case described in this report) have been identified in China. We summarize the Chinese literature's clinical characteristics, immunohistochemical results, treatments, and prognosis of 53 cases. Results: Based on our literature survey, 53 cases of TL-LGNPPA (including the case described in this report) have been reported in China. We found TL-LGNPPA and papillary thyroid carcinoma were positive for TTF-1 and CK19. TL-LGNPPA was negative for TG and PAX-8, whereas papillary thyroid carcinoma was positive for TG and PAX-8. However, negative expression of TTF-1 and positive expression of TG were also found in some TL-LGNPPA cases. Our literature survey found that all TL-LGNPPA cases were negative for PAX-8. Therefore, we suggest that simultaneous immunohistochemical determination of TTF-1 and CK19, as well as TG and PAX-8, can increase the diagnostic accuracy of TL-LGNPPA. Conclusion: The 4th edition of the World Health Organization Classification of Head and Neck Tumors (WHO-HNT) indicates that NPPA with positive expression of cytokeratin 19 (CK19) and TTF-1 and negative expression of TG is called TL-LGNPPA.
Lung cancer is the leading cause of cancer-related deaths worldwide, and has the highest morbidity among all cancers. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases and its most common subtypes are lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Although the selenium protein gene plays a key role in the initiation, development, and progression of many cancers, the panoramic picture of the involvement of selenoprotein gene family in LUAD and LUSC is unclear. Therefore, the expression and prognostic value of the selenoprotein family genes, as well as their potential mechanisms in LUAD and LUSC, were systematically examined in this study. First, differential expression and survival analyses revealed that a high expression of glutathione peroxidase 2 (GPX2) and low expression of both GPX3 and selenoprotein P (SELENOP) in tumors correlated with poor overall survival in patients with LUAD, while a high expression of iodothyronine deiodinase 2 (DIO2) in tumors correlated with better overall survival, and a low expression of GPX3 correlated with poor overall survival in patients with LUSC. Next, we developed a nomogram based on the Cox regression model to visualize survival and confirmed its predictive capability. Methylation, gene mutation, and immune infiltration analyses of selenoprotein genes indicated that they all participated in the progression of LUAD and LUSC. Enrichment analysis and protein–protein interaction networks showed that the common differentially expressed genes mainly participated in selenocompound metabolism, glutathione metabolism, arachidonic acid metabolism, and thyroid hormone synthesis. In addition, we constructed transcription factor (TF)-mRNA, mRNA-RNA-binding protein (RBP), and mRNA-drug regulatory networks. Our research shows that selenoprotein family members have potential as novel biomarkers for prognostic assessment and as therapeutic targets for LUAD and LUSC.